Roger Pomerantz, President and CEO at Seres Therapeutics, Inc. (MCRB), sold 16,706 shares at $24.28 ($406K) on 2016-05-06, disclosed to the SEC on 2016-05-09.
Open-market sale of $406k MCRB by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.28 | 8,199 | $199K | 49.0% |
| 2 | $24.28 | 8,199 | $199K | 49.0% |
| 3 | $25.10 | 308 | $8K | 1.9% |
| Total | $24.30 avg | 16,706 | $406K | 100% |
| Filing → |
| RUBY | BUY | 2018-07-23 | $2K | — | Filing → |
| MCRB | SELL | 2018-07-12 | $9K | — | Filing → |
| MCRB | SELL | 2018-07-10 | $590K | — | Filing → |